175205-55-7 Usage
Uses
Used in Pharmaceutical Synthesis:
3-Bromo-5-chloro-4-iodobenzotrifluoride is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with improved therapeutic properties and reduced side effects.
Used in Agrochemical Production:
In the agrochemical industry, 3-Bromo-5-chloro-4-iodobenzotrifluoride serves as a crucial component in the creation of novel pesticides and herbicides. Its incorporation into these products enhances their effectiveness in controlling pests and weeds, thereby improving crop yields and quality.
Used in Fine Chemicals Synthesis:
3-Bromo-5-chloro-4-iodobenzotrifluoride is also employed as a building block in the synthesis of fine chemicals, which are high-purity chemicals used in various applications such as fragrances, dyes, and specialty chemicals. Its unique properties contribute to the development of innovative and high-quality products in this field.
Safety Considerations:
Due to its potential health hazards and risks associated with handling and exposure, 3-Bromo-5-chloro-4-iodobenzotrifluoride must be handled with care. Proper safety measures, including the use of personal protective equipment and adherence to safety protocols, are essential to minimize the risks associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 175205-55-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,2,0 and 5 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 175205-55:
(8*1)+(7*7)+(6*5)+(5*2)+(4*0)+(3*5)+(2*5)+(1*5)=127
127 % 10 = 7
So 175205-55-7 is a valid CAS Registry Number.
175205-55-7Relevant academic research and scientific papers
PICOLINAMIDO-PROPANOIC ACID DERIVATIVES USEFUL AS GLUCAGON RECEPTOR ANTAGONISTS
-
Page/Page column 55, (2012/12/13)
The present invention is directed to picolanmido-propanoic acid derivatives, pharmaceutical compositions containing them and their use in the treatment and/or prevention of disorders and conditions ameliorated by antagonizing one or more glucagon receptors, including for example metabolic diseases such as Type II diabetes mellitus and obesity.
